109 results found.
BARE BONES® - April 12, 2013
Medicrea posted 1Q13 sales of €5.3MM (~US $7MM), +11% from 1Q12. (U.S. subsidiary +22%) (Medicr...
BARE BONES® - March 21, 2013
MEDICREA received FDA clearance for the PASS® LP thoraco-lumbar fixation system for adolescent scoliosis. Using the ST2R technique (Simultaneous Translation on 2 Rods), PASS ...
BARE BONES® - March 13, 2013
KEY STRATEGIC 510(k)s MARCH 2013 Solus Anterior Lumbar Interbody Fusion System (ALPHATEC SPINE) X-Fix Dynamic External Distractor (AREX) SP2 Femoral and Tibial Locking Nails (BIOMECANICA) Small and Medium Bone...
4Q12 and 2012 Revenue: Medicrea
€20.7MM (~US $27.4MM), +9% 4Q12 revenue: $6.5MM, +20% (U.S. +41%) Expecting recovery of U.S. economic activity in 2013 PASS LP thoracolumbar fixation system >80% of sales Commenced negotiations with U.S. partners to dis...
BARE BONES® - January 16, 2013
Medicrea posted 2012 sales of €20.7MM (~US $27.4MM), +9% from 2011. The company's U.S. subsidiary 4Q12 sales grew 41% over 4Q11. (
BARE BONES® - October 12, 2012
MEDICREA posted 3Q12 sales of €5.0MM (~US $6.4MM), +25% from 3Q11. (The MEDICREA Group, 10/12/12)
3Q12 Earnings: Medicrea
€5.0MM (~US $6.4MM), +25% Launched final stage of validation protocol for K-JAWS implant, hopeful for FDA clearaing in 1Q13
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - July 13, 2012
Medicrea posted 1H12 sales of €10.8MM (~US $13.1MM), +32% from 1H11, and 2Q12 sales of ~$7.3MM, +3% from 2Q11. (
BARE BONES® - June 1, 2012
Medicrea received FDA clearance to market the LigaPASS™ spinal fixation system, and marked the 1st LigaPASS procedures performed in the U.S. LigaPASS comprises a rod connector an...
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
BARE BONES® - April 6, 2012
Medicrea posted 1Q12 sales of €4.9MM (~$6.4MM), +20% from 1Q11. (Medicrea, 4/6/12) ...
The Next Look at 2011 Results
ORTHOWORLD’s preliminary estimates place overall 2011 market growth at 5% over 2010, as displayed in Exhibit 1. Performance highlights follow, and address both 4Q10 and 2011, as indicated.                                      ...
BARE BONES® - February 8, 2012
Medicrea announced FDA clearance and the 1st U.S. procedure performed using the PASS minimally invasive surgical system. The system enables both short and multi level complex constructs to be performed via a
BARE BONES® - February 7, 2012
KEY STRATEGIC 510(k)s FEBRUARY 2012 Acu-Cut Vertebral Augmentation System (ASCENDX SPINE) Polyfuse - Neurobone Bone Void Filler (ATPAC MEDICAL) Eaum Total Knee (CORENTEC) Pass LP Spinal (MEDICREA) Extremity Fixation Implan...
BARE BONES® - November 15, 2011
New products introduced by Medicrea include the GRANVIA-L® hybrid lumbar disc, PASS-MIS® surgical technique, CARYTID® VBR corporectomy implant (made with additive manufacturing
3Q11: A First Look at Financials: Medicrea
MEDICREA €4.0MM (~US $5.5MM), -13% * PASS-LP polyaxial system accounts for ~75% of revenue * Low growth partially attributed to time taken to get new sales staff up to speed * Unveiled 6 new products, including GRANVIA-L hybrid lumbar di...
First Look at 2Q11 Results: Medicrea
MEDICREA €5.8MM (~US $8.2MM), +29% * Best performance to date for U.S. subsidiary, mainly attributable to PASS LP thoracolumbar fixation system
BARE BONES® - July 15, 2011
MEDICREA launched a pre-Investigational Device Exemption U.S. pilot trial of the GRANVIA®-C cervical disc, involving 60 patients at 2-year follow-up. (MEDICREA, 6/30/11)
First Look at 1Q11 Results: Medicrea
MEDICREA €5.2MM (~US $7.4MM), +53% * U.S. sales ~50% of activity
Orthopaedic Sales Increases By Product Segment: 2010 vs. 2009

A First Look at 2010 Results: Medicrea
MEDICREA * €18.2MM (~US $24.3MM), +39% (U.S. ~$12MM, +50%) * PASS LP platform = ~75% of group sales * Granvia C cervical disc = 5% of group sales * 250 patients treated to date using Granvia C
ORTHOKNOW® - November 10, 2010
QUARTERLY REVIEW3Q10 Company FinancialsHere is the first look at select company financials for 3Q. Our estimates place year over year overall market growth at 4%, as indicated in Exhibit 1, which displays growth by product segment. Performance highlights relate to 3Q10, unless o...
BARE BONES® - August 11, 2010
ORTHOPAEDIC STRATEGIC INITIATIVESAMEDICA entered into an agreement whereby SUNY Upstate Medical University will conduct a 2-year research study to evaluate fusion performance of the company’s silicon nitride ceramic technology vs. PEEK interbody fusion devices.  (Amedica ...
ORTHOKNOW® - August 11, 2010
QUARTERLY REVIEWCompany FinancialsHere we present the first look at 2Q10 financial reports. Our estimates place overall market growth at 5% over 2Q09, as seen in Exhibit 1, which also displays 2Q orthopaedic sales growth by product segment for select companies. Performance highl...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group